A new report published in the Journal of Occupational and Environmental Medicine indicated that mesothelioma is a risk no matter how high or low the level of asbestos exposure occurs. The information was culled from data gathered as part of the Netherlands Cohort Study, a study that has been conducted since 1986 that involves over
Those mesothelioma patients that have already undergone a chemotherapeutic course course of pemetrexed may gain benefits from undergoing a second course with a different medication known as vinorelbine. Though Pemetrexed and a platinum-based medication called cisplatin are the most traditional first-line course of chemotherapy treatment used in mesothelioma patients, physicians have found that the use
A study presented at the 15th World Conference on Lung Cancer has provided controversial information. It indicates that when the patients who are deemed healthiest among mesothelioma victims undergo surgery, it does not provide an appreciable improvement in the patient’s survival rates. The study was conducted in Italy and included data from almost 1,400 patients
The results of a new study were released by researchers from the Queen Mary’s Barts Cancer Institute in London, and they offer great promise for those hoping to slow down or stop the growth of mesothelioma tumors. The results, which revolved around the application of a new drug that is designed to deprive the tumor
A recent study conducted by scientists at Papworth Hospital in Cambridge, United Kingdom,indicated that an invasive keyhole surgery called video-assisted thoracoscopic surgery, or VATS, does nothing to extend mesothelioma patients’ survival rates but does make a considerable improvement in their quality of life. The study was presented at the 15th World Conference on Lung Cancer.
For those who work in health advocacy, and particularly those who focus on asbestos-related diseases, news of loss and waste as a result of exposure to asbestos is nothing new. But a recent report by the World Health Organization (WHO) shocked even those who work with bad news every day. The report, which was published
Though every mesothelioma lawsuit is different, attorneys follow a standard process to ensure the best possible outcome. One of the most important phases of litigation is discovery. This pre-trial period involves the gathering and exchange of information between all parties. A thorough discovery process can make all the difference in whether your case settles out
Artificial Intelligence is revolutionizing many aspects of life, including how doctors approach mesothelioma diagnosis, treatment, and patient care. Advanced computational technologies are improving diagnostic accuracy, speeding up investigational processes, and personalizing treatment approaches. From predicting patient outcomes to discovering novel therapies, AI is transforming mesothelioma care in ways that were unimaginable just a few years ago and
Mesothelioma researchers from Milan, Italy, have discovered that mesothelioma cells can transform themselves into fibroblast-like cells within their tumors. Their findings challenge the conventional understanding of how the rare cancer’s microenvironment forms and functions.
Mesothelioma patients whose disease progressed after receiving a first-line treatment of nivolumab plus ipilimumab achieved a 60 percent objective response rate when treated with second-line pembrolizumab plus lenvatinib therapy. Dutch researchers report that twenty patients experienced a median progression-free survival of 6.9 months and disease control rates of 90 percent at 3 months and 52.6